Reckitt Benckiser (RB), British household goods firm has decided to spin off its US-based pharmaceuticals division, it announced after a strategic review. The company will float the unit, RB Pharmaceuticals, on the London stock market later this year, it said in a statement which also revealed that first-half net profits jumped by almost a quarter. "We believe that RB Pharmaceuticals has the potential to deliver significant long term value creation ...
Read More
You have just read an article categorized health
titled Reckitt Benckiser to Spin Off Its US-Based Pharmaceuticals Arm.
Written by:
editor -
Monday, July 28, 2014
There are currently no comments for "Reckitt Benckiser to Spin Off Its US-Based Pharmaceuticals Arm"
Post a Comment